Resource use and costs of branch and central retinal vein occlusion in the elderly

Author： Fekrat Sharon   Shea Alisa M.   Hammill Bradley G.   Nguyen Hiep   Kowalski Jonathan W.   Schulman Kevin A.   Curtis Lesley H.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.1, 2010-01, pp. : 223-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Membranous nephropathy and central retinal vein occlusion

By  

NEPHROLOGY, Vol. 20, Iss. 9, 2015-09 ,pp. : 668-669

John Wiley & Sons Inc

Access to resources Recommend Favorite

One‐year treatment outcomes of ziv‐aflibercept for treatment‐naïve macular oedema in branch retinal vein occlusion

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e256-e257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Head‐to‐head comparison of ranibizumab PRN versus single‐dose dexamethasone for branch retinal vein occlusion (COMRADE‐B)

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 1, 2018-02 ,pp. : e10-e18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Injections in retinal vein occlusions

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 42, Iss. 7, 2014-09 ,pp. : 650-655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy of macular oedema: meta‐analysis

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 42, Iss. 7, 2014-09 ,pp. : 637-649

John Wiley & Sons Inc

Access to resources Recommend Favorite